Synergistic Combinations for Enhanced Inflammatory Bowel Disease Treatment

Integrating peripheral nerve stimulation with AI, IoT, blockchain, and new materials to create a more effective and personalized treatment system for inflammatory bowel disease.

The original patent disclosed systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation. However, these methods have limitations in terms of data management, predictive analytics, and personalized treatment. The new inventive concept addresses these limitations by combining peripheral nerve stimulation with emerging technologies to create a more comprehensive and effective treatment system.

The new inventive concept consists of a peripheral nerve stimulator configured to modulate autonomic tone, which is integrated with a blockchain-based patient data management module for secure data storage and sharing. An AI-powered predictive analytics engine optimizes stimulation parameters based on patient response. Additionally, the system may include an IoT-enabled sensor module for monitoring physiological parameters and a cloud-based AI platform for analyzing sensor data and adjusting stimulation parameters. Alternatively, a new material-based implantable device can be used for delivering electrical stimulation signals. The synergistic combination of these technologies enables a more personalized and effective treatment approach.

The new claims introduce the novel combination of peripheral nerve stimulation with AI, IoT, blockchain, and new materials, which provides a significant improvement over the original patent. The integration of these technologies enables a more comprehensive and personalized treatment system, which is not obvious from the original patent.

Other embodiments of the inventive concept may include using different types of sensors or data analytics platforms, integrating with electronic health records, or incorporating machine learning algorithms for predictive modeling. Variations may also include using different materials or implantable devices, or incorporating additional features such as patient feedback mechanisms or remote monitoring capabilities.

The inventive concept has significant commercial potential in the treatment of inflammatory bowel disease, with potential applications in personalized medicine, telehealth, and digital therapeutics. The target market includes pharmaceutical companies, medical device manufacturers, and healthcare providers seeking innovative solutions for chronic disease management.